Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
Cancer Res
; 61(12): 4892-900, 2001 Jun 15.
Article
in En
| MEDLINE
| ID: mdl-11406568
Search on Google
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Breast Neoplasms
/
Membrane Glycoproteins
/
Tumor Necrosis Factor-alpha
/
Protein Serine-Threonine Kinases
/
Apoptosis
/
Receptor, ErbB-2
/
Antibodies, Monoclonal
/
Antineoplastic Agents
Limits:
Female
/
Humans
Language:
En
Year:
2001
Type:
Article